Clinical Trial Update: Oncolytic Virus in Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating an oncolytic virus therapy for esophageal squamous cell carcinoma is currently recruiting, sponsored by Sichuan University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Oncolytic virus

Snippet

Sponsor: Sichuan University | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: RECRUITING